IPIXライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 04:33):

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective...

Stats
本日の出来高	161 805
平均出来高	572 329
時価総額	1.54M
EPS	$0 ( 2024-04-12 )
次の収益日	( $0 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.300
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2022-12-30	Ehrlich Leo	Sell	11 307 527	Class B Common Stock
2021-10-10	Harness Jane A.	Buy	500 000	Stock Option
2020-09-11	Harness Jane A.	Buy	58 394	Class A Common Stock
2019-09-01	Harness Jane A.	Buy	58 394	Class A Common Stock
2020-09-11	Harness Jane A.	Sell	21 606	Class A Common Stock

INSIDER POWER
-100.00
Last 91 transactions
Buy: 118 435 245 \| Sell: 65 639 262

Innovation 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Innovation 財務諸表

Annual	2023
収益:	$0
総利益:	$-373 000 (0.00 %)
EPS:	$-0.00630

FY	2023
収益:	$0
総利益:	$-373 000 (0.00 %)
EPS:	$-0.00630

FY	2022
収益:	$18 000.00
総利益:	$-364 000 (-2 022.22 %)
EPS:	$-0.0142

FY	2021
収益:	$0.00
総利益:	$0.00 (0.00 %)
EPS:	$-0.0400

Financial Reports:

No articles found.

Innovation

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company is also developing Kevetrin, an anti-cancer compound for treating ovarian cancer. It has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.